ReviewMolecules (Basel, Switzerland)2023

Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs.

Maria Giulia Nizi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.